OPIANT PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q1 2014 to Q3 2022

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Opiant Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q1 2014 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2022 was 836 %, a 11.8% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 836 -112 -11.8% Sep 30, 2022
Q2 2022 939 +75.7 +8.76% Jun 30, 2022
Q1 2022 959 +161 +20.2% Mar 31, 2022
Q4 2021 971 +191 +24.5% Dec 31, 2021
Q3 2021 948 +230 +32.1% Sep 30, 2021
Q2 2021 863 +227 +35.6% Jun 30, 2021
Q1 2021 798 +279 +53.9% Mar 31, 2021
Q4 2020 779 +375 +92.7% Dec 31, 2020
Q3 2020 717 +385 +116% Sep 30, 2020
Q2 2020 636 +279 +78% Jun 30, 2020
Q1 2020 518 +154 +42.3% Mar 31, 2020
Q4 2019 405 +34.3 +9.26% Dec 31, 2019
Q3 2019 333 -72.9 -18% Sep 30, 2019
Q2 2019 358 +77.3 +27.6% Jun 30, 2019
Q1 2019 364 +102 +38.8% Mar 31, 2019
Q4 2018 370 +92.2 +33.2% Dec 31, 2018
Q3 2018 405 +166 +69.3% Sep 30, 2018
Q2 2018 280 +74.4 +36.2% Jun 30, 2018
Q1 2018 263 +109 +71.1% Mar 31, 2018
Q4 2017 278 +173 +164% Dec 31, 2017
Q3 2017 239 +195 +438% Oct 31, 2017
Q2 2017 206 +168 +443% Jul 31, 2017
Q1 2017 153 +123 +403% Apr 30, 2017
Q4 2016 105 +78.7 +297% Jan 31, 2017
Q3 2016 44.5 +16.3 +57.7% Oct 31, 2016
Q2 2016 37.9 -6.62 -14.9% Jul 31, 2016
Q1 2016 30.5 -20 -39.6% Apr 30, 2016
Q4 2015 26.5 -15.3 -36.6% Jan 31, 2016
Q3 2015 28.2 -10.9 -27.8% Oct 31, 2015
Q2 2015 44.5 +23.7 +114% Jul 31, 2015
Q1 2015 50.5 +18.3 +57% Apr 30, 2015
Q4 2014 41.8 Jan 31, 2015
Q3 2014 39.1 Oct 31, 2014
Q2 2014 20.8 Jul 31, 2014
Q1 2014 32.2 Apr 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.